Skip to main content
Premium Trial:

Request an Annual Quote

To Smith a Grant

For those kicking off the year with working on grant applications, the National Institute of Allergy and Infectious Disease has posted examples of "exceptional R01 applications in the shorter format," as the institute's blog points out here. The four examples are annotated to point out their "excellent grantsmanship attributes." For example, in the application from the Broad Institute's Carolina Wahlby, the NIAID staff indicates the parts of the significance portion of her research strategy section that gives background information about the project, shows how it relates to her recent work, identifies a gap in the field, and describes how the project is related to human health.

In a comment on the NIAID blog and on his own blog, DrugMonkey says he'd also like to see examples of good applications that were not funded. "My bet is that they could have easily put up a few selected near-miss applications and similarly noted ... the excellent grantsmithing," DrugMonkey writes at his blog. "Similarly, you can go through these awEsomeZ! applications and find sections that violate fairly basic grantwriting advice."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.